Exosome-mediated breast cancer chemoresistance via miR-155 transfer

Autor(es)

Santos, Juliana Carvalho ^[1] ; Lima, Natalia da Silva ^[2] ; Sarian, Luis Otavio ^[1] ; Matheu, Ander ^[3] ; Ribeiro, Marcelo Lima ^[2] ; Mauricette Derchain, Sophie Francoise ^[1]

Afiliação do(s) autor(es)

^[1] State Univ Campinas UNICAMP, Womens Hlth Hosp Prof Dr Jose Aristodemo Pinotti, Campinas, SP - Brazil

^[2] Sao Francisco Univ, Clin Pharmacol & Gastroenterol Unit, Braganca Paulista, SP - Brazil

^[3] Biodonostia Hlth Res Inst, Cellular Oncol Grp, San Sebastian - Spain

• Tipo de documento: Artigo Científico
• Fonte: SCIENTIFIC REPORTS; v. 8, JAN 16 2018.
• Citações Web of Science: 45

Resumo

Breast cancer remains the most prevalent cause of cancer mortality in woman worldwide due to the metastatic process and therapy resistance. Resistance against cancer therapy is partially attributed to cancer stem cells (CSCs). These cells arise from epithelial cells undergoing epithelial-to-mesenchymal transition (EMT) and might be responsible for tumor recurrence. In this study, we reported the relevance of miR-155 upregulation in chemoresistant cells associated with EMT. Notably, we found miR-155 induction in exosomes isolated from CSCs and resistant cells, followed by resistant cells' exosome transfer to the recipient sensitive cells. Functionally, miR-155 mimic assay showed an enrichment in miR-155 from exosome concomitant with miR-155 exosome transfer to breast cancer cells. In parallel to these effects, we also observed EMT change in miR-155 transfected cells. The chemoresistance phenotype transfer to sensitive cells and the migration capability was analyzed by MTT and scratch assays and our results suggest that exosomes may intermediate resistance and migration capacity to sensitive cells partly through exosome transfer of miR-155. Taken together, our findings establish the significance of exosome-mediate miR-155 chemoresistance in breast cancer cells, with implications for targeting miR-155 signaling as a possible therapeutic strategy. (AU)

• Processo FAPESP: 15/25056-4 - Análise de biomarcadores moleculares associados à quimiorresistência mediada por células tronco tumorais de mama
• Beneficiário: Juliana Carvalho Santos
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 16/07822-4 - Análise De Biomarcadores Moleculares Associados À Quimiorresistência Mediada Por Células Tronco Tumorais De Mama
• Beneficiário: Sophie Françoise Mauricette Derchain
• Modalidade de apoio: Auxílio à Pesquisa - Regular